Medtronic PLC: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Medtronic PLC Unternehmen

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Medtronic PLC Informationen



BörsenkürzelMDT

Name des UnternehmensMedtronic PLC

IPO-datumNov 21, 1977

CEOMr. Geoffrey S. (Geoff) Martha

Anzahl der mitarbeiter95000

WertpapierartOrdinary Share

GeschäftsjahresendeNov 21

AddresseBuilding Two Parkmore Business Park West

StadtDUBLIN

BörseNYSE Consolidated

LandIreland

PostleitzahlH91 4K49

Telefon1135314381700

Websitehttps://www.medtronic.com/

BörsenkürzelMDT

IPO-datumNov 21, 1977

CEOMr. Geoffrey S. (Geoff) Martha

Führungskräfte von Medtronic PLC



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.90M

+78.68%

Mr. Brett A. Wall

Executive Vice President, President - Neuroscience Portfolio

548.61K

+10.51%

Mr. Gregory L. Smith

Executive Vice President - Enterprise Operations

186.13K

+56.07%

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.34K

-6.34%

Mr. Michael Marinaro

Executive Vice President, President - Medical Surgical Portfolio and Americas

49.63K

+1.73%

Mr. Kendall J. (Ken) Powell

Independent Director

48.84K

+1.86%

Mr. Craig Arnold

Lead Independent Director

40.24K

+0.18%

Mr. Scott C. Donnelly

Independent Director

21.71K

+0.89%

Dr. Elizabeth G. (Betsy) Nabel, M.D.

Independent Director

17.64K

+0.41%

Mr. Kevin E. Lofton

Independent Director

8.19K

+0.89%

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.90M

+78.68%

Mr. Brett A. Wall

Executive Vice President, President - Neuroscience Portfolio

548.61K

+10.51%

Mr. Gregory L. Smith

Executive Vice President - Enterprise Operations

186.13K

+56.07%

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.34K

-6.34%

Mr. Michael Marinaro

Executive Vice President, President - Medical Surgical Portfolio and Americas

49.63K

+1.73%

Mr. Kendall J. (Ken) Powell

Independent Director

48.84K

+1.86%

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Oct 6

FY2026Q1

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Cardiac Rhythm & Heart Failure

1.71B

19.96%

Surgical & Endoscopy

1.61B

18.79%

Cranial & Spinal Technologies

1.21B

14.12%

Coronary & Peripheral Vascular

930.00M

10.84%

Specialty Therapies

702.00M

8.18%

Andere

2.41B

28.11%

Nach RegionUSD

Name

Umsatz

Anteil

Rest of World

4.32B

50.37%

United States

4.22B

49.24%

Ireland

33.00M

0.38%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Cardiac Rhythm & Heart Failure

1.71B

19.96%

Surgical & Endoscopy

1.61B

18.79%

Cranial & Spinal Technologies

1.21B

14.12%

Coronary & Peripheral Vascular

930.00M

10.84%

Specialty Therapies

702.00M

8.18%

Andere

2.41B

28.11%

Aktionärsstatistik

Aktualisiert: Fri, Aug 15

Aktionäre

Aktionärstypen

Aktionäre

Anteil

The Vanguard Group, Inc.

9.85%

BlackRock Institutional Trust Company, N.A.

5.29%

State Street Investment Management (US)

4.67%

Capital Research Global Investors

2.83%

Geode Capital Management, L.L.C.

2.20%

Andere

75.16%

Aktionäre

Anteil

The Vanguard Group, Inc.

9.85%

BlackRock Institutional Trust Company, N.A.

5.29%

State Street Investment Management (US)

4.67%

Capital Research Global Investors

2.83%

Geode Capital Management, L.L.C.

2.20%

Andere

75.16%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

44.97%

Investment Advisor/Hedge Fund

29.17%

Research Firm

4.57%

Pension Fund

2.28%

Hedge Fund

2.25%

Bank and Trust

2.05%

Sovereign Wealth Fund

1.37%

Insurance Company

0.37%

Individual Investor

0.29%

Andere

12.70%

Institutionelle Beteiligung



Aktualisiert: Wed, Oct 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q3

3658

1.12B

87.15%

-15.13M

2025Q2

3762

1.12B

87.12%

-18.03M

2025Q1

3818

1.13B

88.15%

+2.18M

2024Q4

3768

1.12B

87.17%

+3.13M

2024Q3

3708

1.10B

85.63%

-24.55M

2024Q2

3725

1.11B

86.25%

-54.16M

2024Q1

3789

1.14B

85.95%

-7.87M

2023Q4

3780

1.13B

85.36%

-20.57M

2023Q3

3761

1.14B

85.37%

-14.93M

2023Q2

3764

1.13B

85.01%

-24.32M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

The Vanguard Group, Inc.

126.32M

9.85%

+1.88M

+1.51%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

67.84M

5.29%

-1.09M

-1.58%

Jun 30, 2025

State Street Investment Management (US)

59.83M

4.66%

-210.22K

-0.35%

Jun 30, 2025

Capital Research Global Investors

36.36M

2.83%

-5.21M

-12.53%

Jun 30, 2025

Geode Capital Management, L.L.C.

28.23M

2.2%

+310.68K

+1.11%

Jun 30, 2025

JP Morgan Asset Management

26.31M

2.05%

-1.69M

-6.03%

Jun 30, 2025

MFS Investment Management

19.36M

1.51%

-1.24M

-6.04%

Jun 30, 2025

Norges Bank Investment Management (NBIM)

16.44M

1.28%

+1.87M

+12.83%

Jun 30, 2025

BlackRock Financial Management, Inc.

15.63M

1.22%

+1.48M

+10.48%

Jun 30, 2025

Goldman Sachs & Company, Inc.

14.73M

1.15%

+11.21M

+319.35%

Jun 30, 2025

Verbundene ETFs



Aktualisiert: Mon, Oct 6

Name

Anteil

iShares U.S. Medical Devices ETF

4.68%

Cullen Enhanced Equity Income ETF

3.96%

USCF Dividend Income Fund

3.7%

iShares Health Innovation Active ETF

3.53%

First Trust Active Global Quality Income ETF

3.2%

Tema Heart & Health ETF

3.03%

Global X Aging Population ETF

2.95%

Morgan Dempsey Large Cap Value ETF

2.87%

Madison Covered Call ETF

2.8%

Madison Dividend Value ETF

2.56%

iShares U.S. Medical Devices ETF

Anteil4.68%

Cullen Enhanced Equity Income ETF

Anteil3.96%

USCF Dividend Income Fund

Anteil3.7%

iShares Health Innovation Active ETF

Anteil3.53%

First Trust Active Global Quality Income ETF

Anteil3.2%

Tema Heart & Health ETF

Anteil3.03%

Global X Aging Population ETF

Anteil2.95%

Morgan Dempsey Large Cap Value ETF

Anteil2.87%

Madison Covered Call ETF

Anteil2.8%

Madison Dividend Value ETF

Anteil2.56%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 17.37B USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Mar 06, 2025

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option

Mar 28, 2025

Apr 11, 2025

Mar 28, 2025

Dec 05, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option

Dec 27, 2024

Jan 10, 2025

Dec 27, 2024

Aug 16, 2024

MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option

Sep 27, 2024

Oct 11, 2024

Sep 27, 2024

May 23, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option

Jun 28, 2024

Jul 12, 2024

Jun 28, 2024

Mar 07, 2024

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option

Mar 22, 2024

Apr 12, 2024

Mar 21, 2024

Dec 07, 2023

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023

Dec 20, 2023

Jan 12, 2024

Dec 19, 2023

Aug 17, 2023

MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option

Sep 22, 2023

Oct 13, 2023

Sep 21, 2023

May 25, 2023

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option

Jun 23, 2023

Jul 14, 2023

Jun 22, 2023

Mar 02, 2023

MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Apr 14, 2023 going ex on Mar 23, 2023

Mar 24, 2023

Apr 14, 2023

Mar 23, 2023

Dec 08, 2022

MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Jan 13, 2023 going ex on Dec 20, 2022

Dec 21, 2022

Jan 13, 2023

Dec 20, 2022

Aktien-Split



Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten